Brightsurf Science News and Current Science News Events
 

Angiogenesis Cancer News | Angiogenesis Cancer Current Events
Page 4 of 93 | 2314 Results
Previous0102030405060708091011   Next   
Sort By: Page Views | Date
Angiotensin inhibitors and receptor blockers linked to lower risk of nonmelanoma skin cancer
The use of angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) was associated with a reduced risk of basal cell or squamous cell skin cancers in U.S. veterans, researchers report in the August 26 online issue of the Journal of the National Cancer Institute.   view more (2008-08-27)

Pioneering study looks at p53's role in tumor-stroma interactions
Researchers at Emory University's Winship Cancer Institute have conducted the first comprehensive study of the role an important tumor suppressor gene plays in cancer development.   view more (2006-10-26)

Drugs to inhibit blood vessel growth show promise in rat model of deadly brain tumor
In a landmark study, Medical College of Wisconsin researchers in Milwaukee report that drugs used to inhibit a specific fatty acid in rat brains with glioblastoma-like tumors not only reduced new blood vessel growth and tumor size dramatically, but also prolonged survival. The study is the featured... view more (2008-08-22)

Gladstone scientists identify single microRNA that controls blood vessel development
Scientists from the Gladstone Institute of Cardiovascular Disease (GICD) and UCSF have identified a key regulatory factor that controls development of the human vascular system, the extensive network of arteries, veins, and capillaries that allow blood to reach all tissues and organs.   view more (2008-08-12)

Who gets cancer treatment, and who completes it?
Cancer treatment is now very effective in many cases, yet not all patients with cancer are referred and not all complete their treatment programme. This has puzzled cancer specialists who have wondered if psychological factors might influence their decision and has led to research carried out by Dr... view more (2002-11-13)

Compound reveals new link between signaling protein and cell migration
University of Illinois at Chicago researchers report that a protein that regulates key signaling pathways in cells also plays a role in controlling the active movement or migration of cells.   view more (2005-09-26)

Neuroblastoma expert reviews progress and challenges in fighting difficult pediatric cancer
Childhood cancers are fortunately rare, but among them, neuroblastoma is a special case, accounting for 7 percent of all childhood cancers, but 15 percent of childhood cancer deaths.   view more (2007-06-25)

Potent spice works to block growth of melanoma in lab test
Curcumin, the pungent yellow spice found in both turmeric and curry powders, blocks a key biological pathway needed for development of melanoma and other cancers, say researchers from The University of Texas M. D. Anderson Cancer Center.   view more (2005-07-13)

Comment from Professor Nick Lemoine, Director of Imperial Cancer Research Fund's Molecular Oncology Unit at the Hammersmith Hospital, in response to US research* that has linked breast cancer to a virus:
Comment from Professor Nick Lemoine, Director of Imperial Cancer Research Fund's Molecular Oncology Unit at the Hammersmith Hospital, in response to US research* that has linked breast cancer to a virus:   view more (1999-08-11)

Preclinical study shows chronic stress agitates ovarian cancer; reducing stress slows tumor growth
When mice with ovarian cancer are stressed, their tumors grow and spread more quickly, but that effect can be blocked using a medication commonly prescribed for heart disease.   view more (2006-07-24)

PROSTATE CANCER SERIES (p 859)
A four-week series about prostate cancer-the third most common cancer in men worldwide, and the leading male cancer in Europe and North America-begins in this week's issue of THE LANCET. The first article, by Henrik Grönberg of Umea University, Sweden, assesses the epidemiology of prostate... view more (2003-03-05)

Mutation of the COX2 gene can double or treble a woman's risk of ovarian cancer
Researchers in Portugal have discovered that a specific mutation of the COX2 gene seems to play a role in the onset of ovarian cancer, increasing women's susceptibility to developing the disease.   view more (2007-09-26)

Family history of breast cancer does not increase risk of womb cancer
A family history of breast cancer does not increase a woman`s chances of developing womb cancer, finds a 20-year study in the Journal of Medical Genetics. Cancers of the lining of the womb (endometrium) and breast share some of the same reproductive, hormonal, and lifestyle risk factors. The... view more (2002-11-01)

Breast cancer drug receives FDA approval
A new use for the breast cancer drug Herceptin was approved by the FDA yesterday, a move that means more treatment options for the 25 percent of breast cancer patients with early-stage HER-2 positive breast cancer.   view more (2006-11-20)

Chemotherapy and tamoxifen reduce risk of second breast cancer
Among breast cancer patients, both chemotherapy and tamoxifen independently reduced the risk of developing a second cancer in the other breast, according to a study published online December 25 in the Journal of the National Cancer Institute. The risk reduction persisted for at least 10 and 5... view more (2007-12-26)

Hebrew University one of 25 institutions involved in new European vasculer genomics network
The Hebrew University of Jerusalem is one of only 25 institutions represented in the European Vascular Genomics Network (EVGN), whose operational launch was announced this week by Inserm, the French National Institute of Health and Medical Research. EVGN is the first European Union-funded network... view more (2004-05-12)

Molecule targets and kills tumor cells, starves blood supply
A man-made chemical compound called ARC causes tumor cells to die but leaves normal cells unharmed.   view more (2006-03-16)

Study reveals a key to blood vessel growth and possible drug target
Researchers have identified a molecular pathway that plays a critical role in the growth of blood vessels. The finding not only offers an important insight into the development of the vascular system during embryonic development but suggests a potential target for inhibiting the blood vessels that... view more (2007-10-15)

Women smokers have higher risk of lung cancer than men smokers, though lower lung cancer death rate
Women who smoke appear to be more susceptible to lung cancer than men who smoke, though women smokers have a lower rate of lung cancer-related death.   view more (2006-07-12)

Increased ovarian cancer risk not found in women with breast cancer family history
Women with a strong family history of breast cancer but who don't have breast cancer genetic mutations can now be reassured that they are not at increased risk for ovarian cancer.   view more (2005-09-21)

Cellular cues identified for stroke recovery
When a stroke strikes, the supply of blood to the part of the brain affected is interrupted, starving it of oxygen. Brain cells can be seriously damaged or die, impairing local brain function.   view more (2006-12-26)

Penn's Abramson Cancer Center part of major phase III study for myeloma
Researchers from the Abramson Cancer Center of the University of Pennsylvania announced today that findings from two large, international clinical trials show unprecedented survival for patients with multiple myeloma, a cancer that occurs in the blood-making cells of bone marrow.   view more (2007-11-26)

Women without regular medical care at increased risk of ovarian cancer
In North America, ovarian cancer is the second most common gynecological cancer and is the leading cause of death among women with gynecological cancer. The high mortality is in part due to the difficulty of detecting and diagnosing this condition at an early stage.   view more (2007-03-27)

Breast asymmetry predicts breast cancer
Women who go on to develop breast cancer tend to have breasts that are less symmetrical than women who don't develop the cancer.   view more (2006-03-20)

New gene silencing therapy for cervical cancer
Researchers at The University of Queensland's (UQ) Centre for Immunology and Cancer Research (CICR), based at the Princess Alexandra Hospital, have pioneered a new approach for the treatment of cervical cancer.   view more (2005-11-17)
Page 4 of 93 | 2314 Results
Previous0102030405060708091011   Next   
Sort By: Page Views | Date
© 2008 BrightSurf.com